Unbranded Biologic Drugs
✉ Email this page to a colleague
FDA Unbranded Biologic Drugs
Applicant | Unbranded Labeller | Biologic Ingredient | Dosage Form | BLA | NDC Stem | Launch Date |
---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc. | HF Acquisition Co LLC, DBA HealthFirst | hyaluronidase human | Injection | 021859 | 51662-1555 | 2021-06-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. | QUALLENT PHARMACEUTICALS HEALTH LLC | adalimumab-adbm | Injection | 761058 | 82009-150 | 2024-04-30 |
Novo Nordisk Inc. | REMEDYREPACK INC. | insulin aspart | Injection | 020986 | 70518-3865 | 2023-09-18 |
Biocon Biologics Inc. | Mylan Specialty L.P. | adalimumab-fkjp | Injection | 761154 | 49502-417 | 2023-07-02 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim Pharmaceuticals, Inc. | adalimumab-adbm | Injection | 761058 | 0597-0575 | 2024-04-30 |
>Applicant | >Unbranded Labeller | >Biologic Ingredient | >Dosage Form | >BLA | >NDC Stem | >Launch Date |